Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/10448
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVolarevic, Vladislav-
dc.contributor.authorLukic, Miodrag-
dc.date.accessioned2021-04-20T15:46:53Z-
dc.date.available2021-04-20T15:46:53Z-
dc.date.issued2012-
dc.identifier.issn0097-6156-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/10448-
dc.description.abstractDespite the fact that all galectins have a galactose-defined specificity, galectin-3 has important pro-inflammatory role while other members of the galectin family, including galectin-1, galectin-2, galectin-4, galectin-9, mainly have anti-inflammatory effects in autoimmune disorders. The basis for such a completely opposite effect of galectin-3 in immune regulation remains unclear and merits further in-depth investigation. It is important that galectin-3 has pro-inflammatory role in T-cell mediated diseases: Con A induced hepatitis, MLD-STZ diabetes, EAE and antigen induced arthritis. Targeting galectin-3 as endogenous inflammatory mediator should serve as a platform for designing novel drugs with aim to prevent or resolve the inflammatory response in T cell mediated autoimmune pathology. © 2012 American Chemical Society.-
dc.rightsrestrictedAccess-
dc.sourceACS Symposium Series-
dc.titleAutoimmune disorders in galectin-3 deficient mice-
dc.typeconferenceObject-
dc.identifier.doi10.1021/bk-2012-1115.ch021-
dc.identifier.scopus2-s2.0-84905235068-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

135

Downloads(s)

4

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.